SEARCH

SEARCH BY CITATION

References

  • 1
    Vandenbroucke JP, Rosing J, Bloemenkamp KWM et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001; 344: 15271535.
  • 2
    Kemmeren JM, Algra A, Grobbee DE. Third generation oral contraceptives and risk of venous thromboembolism: meta-analysis. BMJ 2001; 323: 19.
  • 3
    The European Agency for Evaluation of Medicinal Products (EMEA). EMEA Committee for Proprietary Medicinal Products (CPMP) Public Assessment Report. Combined Oral Contraceptives and Venous Thromboembolism. http://www.emea.eu.int/pdfs/human/regaffair/0220101en.pdf 28 September 2001.
  • 4
    Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 2002; 22: 201210.
  • 5
    The European Agency for Evaluation of Medicinal Products (EMEA). EMEA Committee for Proprietary Medicinal Products (CPMP). Draft note for Guidance on Clinical Investigation of Steroidal Contraceptives in Women. http://www.emea.eu.int/pdfs/human/ewp/051998en.pdf 23 June 2004.
  • 6
    Schering Health Care Ltd. Summary of Manufacturer's Product Characteristics for Yasmin® (drospirenone/ethinylestradiol). July 2002.
  • 7
    Shakir SA. PEM in the UK. In: Pharmacovigilance, 1st edn. eds MannRD, AndrewsE. Chichester: John Wiley & Sons Ltd, 2002: 333344.
  • 8
    Van Grootheest K, Vrieling T. Thromboembolism associated with the new contraceptive Yasmin. BMJ 2003; 326: 257.
  • 9
    Kieler H, Persson I, Odlind V. [Venous thromboembolism and combined oral contraceptives. Reported adverse reactions indicate at least similar risk with the most recent contraceptive pills]. Lakartidningen 2003; 100: 30503052.
  • 10
    Goldhaber SZ. Pulmonary embolism. Lancet 2004; 363: 12951305.
  • 11
    Jick H, Kaye JA, Vasilakis-Scaramozza C et al. Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with Levonorgestrel before and after 1995: cohort and case-control analysis. BMJ 2000; 321: 11901195.
  • 12
    Kelman CW, Kortt MA, Becker NG et al. Deep vein thrombosis and air travel: record linkage study. BMJ 2003; 327: 1072.
  • 13
    Anonymous. Is Yasmin a ‘truly different’ pill? Drugs Therapeutics Bull 2002; 40: 5759.
  • 14
    Goldacre MJ, Roberts S, Yeates D et al. Hospital admission and mortality rates for venous thromboembolism in Oxford region, UK, 1975–98. Lancet 2000; 355: 19681969.